Synthetic Biologics, Inc. (SYN)
R&D Expenses
$5.31M
TTM · Period ending: · USD
SYN R&D Expenses
Latest reported$5.31Mperiod ending
Latest reported$5.31Mperiod ending
SYN TTM R&D Expenses ($1.14M → $5.31M)
TTM R&D Expenses
High-resolution chart · PNG
SYN r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 5,306,000 | |
| 5,991,000 | |
| 8,604,000 | |
| 9,387,000 | |
| 9,789,000 | |
| 11,842,000 | |
| 12,007,000 | |
| 13,069,000 | |
| 12,978,000 | |
| 11,542,000 | |
| 11,894,000 | |
| 11,514,000 | |
| 11,431,000 | |
| 10,833,000 | |
| 9,280,000 | |
| 7,801,000 | |
| 6,001,000 | |
| 4,943,000 | |
| 4,614,000 | |
| 5,131,000 | |
| 6,079,000 | |
| 9,309,000 | |
| 10,300,000 | |
| 11,083,000 | |
| 11,212,000 | |
| 9,914,000 | |
| 10,892,000 | |
| 11,844,000 | |
| 13,544,000 | |
| 14,835,000 | |
| 16,094,000 | |
| 18,783,000 | |
| 21,756,000 | |
| 24,680,000 | |
| 27,013,000 | |
| 29,109,000 | |
| 31,238,000 | |
| 34,223,000 | |
| 34,567,000 | |
| 32,906,000 | |
| 29,290,000 | |
| 22,937,000 | |
| 18,266,000 | |
| 14,489,000 | |
| 11,958,000 | |
| 9,740,000 | |
| 8,106,000 | |
| 6,507,000 | |
| 14,387,000 | |
| 13,675,000 | |
| 13,019,000 | |
| 12,287,000 | |
| 4,235,077 | |
| 3,761,041 | |
| 3,493,682 | |
| 3,340,000 | |
| 974,550 | |
| 1,110,159 | |
| 1,392,996 | |
| 1,579,891 | |
| 1,391,059 | |
| 1,292,148 | |
| 1,135,315 | |
| 1,212,096 | |
| 1,714,616 | |
| 2,252,226 | |
| 3,014,944 | |
| 4,643,570 | |
| 6,414,199 | |
| 7,124,537 | |
| 7,035,224 | |
| 6,327,727 | |
| 6,404,019 | |
| 4,830,409 | |
| 3,751,359 | |
| 2,665,555 | |
| 331,319 | |
| 331,319 | |
| 81,069 | |
| 1,371,886 | |
| 1,371,886 | |
| 1,622,136 | |
| 2,187,791 | |
| 1,096,759 | |
| 2,718,895 | |
| 3,622,435 | |
| 4,640,542 | |
| 5,795,484 | |
| 6,107,710 | |
| 5,999,693 | |
| 5,736,429 | |
| 4,942,794 | |
| 3,891,187 | |
| 3,747,437 | |
| 3,698,923 | |
| 3,706,512 | |
| 3,623,757 | |
| 3,421,734 | |
| 2,800,000 | |
| 2,100,000 |